Skip to Content
Merck
CN
All Photos(1)

Documents

Safety Information

860701P

Avanti

C17:0 GA2

powder

Sign Into View Organizational & Contract Pricing

Synonym(s):
C17:0 Galabiosylceramide
Empirical Formula (Hill Notation):
C47H89NO13
CAS Number:
Molecular Weight:
876.21
UNSPSC Code:
12352211
NACRES:
NA.28

Assay

99% (TLC)

form

powder

packaging

package of 1 × 500 μg (860701P-500UG)

manufacturer/tradename

Avanti Polar Lipids

lipid type

sphingolipids

shipped in

dry ice

storage temp.

−20°C

General description

Galabiosylceramide (Ga2cer) is a glycolipid and is produced in the luminal leaflet of the Golgi apparatus.

Biochem/physiol Actions

Galabiosylceramide (Ga2cer) is accumulated in larger amounts in Fabry′s disease.

Packaging

5 mL Clear Glass Sealed Ampule (860701P-500UG)

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Information

新产品

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Topology of sphingolipid galactosyltransferases in ER and Golgi: trans bilayer movement of mono hexosyl sphingolipids is required for higher glycosphingolipid biosynthesis.
Burger KN, et al.
The Journal of Cell Biology, 133(1), 15-28 (1996)
Accumulation of glycosphingolipids in spinal and sympathetic ganglia of a symptomatic heterozygote of Fabry's disease
Hozumi I, et al.
Journal of the Neurological Sciences, 90(3), 273-280 (1989)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service